CompletedPhase 3NCT00002546
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
Studying Carcinosarcoma of the corpus uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gynecologic Oncology Group
- Principal Investigator
- Aaron H. Wolfson, MDUniversity of Miami Sylvester Comprehensive Cancer Center
- Intervention
- cisplatin(drug)
- Enrollment
- 216 enrolled
- Eligibility
- 21-120 years · FEMALE
- Timeline
- 1993
Study locations (30)
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
- CCOP - Western Regional, Arizona, Phoenix, Arizona, United States
- Women's Cancer Center - Los Gatos, Los Gatos, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center, Orange, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver, Colorado, United States
- CCOP - Christiana Care Health Services, Newark, Delaware, United States
- Walter Reed Army Medical Center, Washington D.C., District of Columbia, United States
- University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
- Rush University Medical Center, Chicago, Illinois, United States
- MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- CCOP - Central Illinois, Decatur, Illinois, United States
- CCOP - Evanston, Evanston, Illinois, United States
- Hinsdale, Illinois, United States
- CCOP - Carle Cancer Center, Urbana, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · Eastern Cooperative Oncology Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002546 on ClinicalTrials.govOther trials for Carcinosarcoma of the corpus uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07029399A Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsNiKang Therapeutics, Inc.
- RECRUITINGPHASE2NCT05619913EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine CarcinosarcomaAustralia New Zealand Gynaecological Oncology Group
- ACTIVE NOT RECRUITINGPHASE2NCT05147558A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine CarcinosarcomaMemorial Sloan Kettering Cancer Center
- RECRUITINGPHASE1, PHASE2NCT03686124ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsImmatics US, Inc.